Page last updated: 2024-09-05

sorafenib and Allergic Cutaneous Angiitis

sorafenib has been researched along with Allergic Cutaneous Angiitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Belev, B; Bulimbašić, S; Kekez, D; Kocić, L; Pleština, S; Prejac, J1
Najarian, DJ; Packianathan, V; Zeitouni, NC1
Chung, NM; Gutierrez, M; Turner, ML1

Other Studies

3 other study(ies) available for sorafenib and Allergic Cutaneous Angiitis

ArticleYear
Leukocytoclastic vasculitis associated with sorafenib treatment for hepatocellular carcinoma.
    Anti-cancer drugs, 2020, Volume: 31, Issue:1

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Sorafenib; Vasculitis, Leukocytoclastic, Cutaneous

2020
Annular leukocytoclastic vasculitis associated with sorafenib administration.
    Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:6

    Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Humans; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Vasculitis, Leukocytoclastic, Cutaneous

2010
Leukocytoclastic vasculitis masquerading as hand-foot syndrome in a patient treated with sorafenib.
    Archives of dermatology, 2006, Volume: 142, Issue:11

    Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Foot; Hand; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Syndrome; Vasculitis, Leukocytoclastic, Cutaneous

2006